Status:

COMPLETED

Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19.

Lead Sponsor:

Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia

Conditions:

COVID19

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Protection of endothelial dysfunction by intravenous infusion of Defibrotide (Defitelio), expected to decrease inflammation and expression of adhesion molecules in the endothelium, leukocyte tissue in...

Detailed Description

Protection of endothelial dysfunction by intravenous infusion of Defibrotide (Defitelio), expected to decrease inflammation and expression of adhesion molecules in the endothelium, leukocyte tissue in...

Eligibility Criteria

Inclusion

  • Acceptance of participation in the study by the patient or legal representative.
  • Patients of any gender, 18 years or older.
  • Confirmed diagnosis by PCR+ of SARS-CoV-2 infection.
  • COVID-19 positive patients WHO grades 4, 5 or 6.
  • Grade 4: hospitalized requiring oxygen therapy.
  • Grade 5: hospitalized requiring high-flow oxygen therapy, noninvasive mechanical ventilation, or both.
  • Levels of IL-6 ≥ 3 times the upper limit of normality

Exclusion

  • Acute bleeding.
  • Thrombolytic treatment and anticoagulant treatment at therapeutic doses.
  • Pregnancy or lactation.
  • Patients with active malignant tumour, other serious systemic or neuropsychiatric diseases.
  • Patients participating in other clinical trials in the last month.
  • Inability to give informed consent or to accomplish the requirements of the diagnostic tests.
  • Patients with hypersensitivity to Defibrotide.

Key Trial Info

Start Date :

April 8 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 28 2023

Estimated Enrollment :

156 Patients enrolled

Trial Details

Trial ID

NCT04348383

Start Date

April 8 2020

End Date

February 28 2023

Last Update

June 7 2023

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Hospital General Universitario Santa Lucía

Cartagena, Murcia, Spain

2

Hospital Clinico y Provincial de Barcelona

Barcelona, Spain

3

Virgen de la Arrixaca University Clinical Hospital

Murcia, Spain, 30120

4

Hospital General Universitario Morales Meseguer

Murcia, Spain